# Final Report: Idea 10

## Final ELO Score: 1203.3

## Final Hypothesis

**Title**: Allosteric Blockade of S. aureus Sortase A via Covalent Reversible Warheads

**Key Idea**: Reversible covalent modifiers that bind the non-catalytic Cys region of Sortase A will inhibit surface protein anchoring and biofilm formation.

**Paragraph**: Sortase A attaches MSCRAMMs to peptidoglycan, facilitating colonisation and immune evasion [Mazmanian 1999]. Traditional irreversible inhibitors risk off-target effects; tunable reversibility offers selectivity and reduced toxicity.

**Approach**: Rational design of cyanoacrylamide-based fragments, kinetic mass spectrometry, biofilm assays on titanium implants, and rabbit endocarditis model.

**Key References**: Mazmanian et al., Science, 1999 [Mazmanian 1999]; Krishnan et al., J. Med. Chem., 2021 (reversible covalent drugs) [Krishnan 2021].

## Comprehensive Analysis

This document provides a full analysis of the idea, including its evolution, strengths, weaknesses, and potential applications. Below we trace the development of this idea through each phase of the research process.

## Evolution History

The idea underwent several iterations during the research process:

## Detailed Breakdown

### Title

Allosteric Blockade of S. aureus Sortase A via Covalent Reversible Warheads

### Key Idea

Reversible covalent modifiers that bind the non-catalytic Cys region of Sortase A will inhibit surface protein anchoring and biofilm formation.

### Detailed Explanation

Sortase A attaches MSCRAMMs to peptidoglycan, facilitating colonisation and immune evasion [Mazmanian 1999]. Traditional irreversible inhibitors risk off-target effects; tunable reversibility offers selectivity and reduced toxicity.

### Implementation Approach

Rational design of cyanoacrylamide-based fragments, kinetic mass spectrometry, biofilm assays on titanium implants, and rabbit endocarditis model.

### Key References

Mazmanian et al., Science, 1999 [Mazmanian 1999]; Krishnan et al., J. Med. Chem., 2021 (reversible covalent drugs) [Krishnan 2021].

## Complete Evolution History

This section documents the complete evolution of the idea through each phase of the research process.

### 1. Initial Generation (Round 1)
**Timestamp:** 2025-05-07 10:18:52



### 2. Reflection (Round 1)
**Timestamp:** 2025-05-07 10:19:54



### 3. Proximity Check (Round 1)
**Timestamp:** 2025-05-07 10:21:01



### 4. Tournament Results
**Timestamp:** 2025-05-07 10:28:02

**ELO Score:** 1191.5



### 5. Mini-Tournament (Round 1)
**Timestamp:** 2025-05-07 10:28:02

**ELO Score:** 1191.5



### 6. Round Summary (Round 1)
**Timestamp:** 2025-05-07 10:29:28



### 7. Reflection (Round 2)
**Timestamp:** 2025-05-07 10:33:12



### 8. Proximity Check (Round 2)
**Timestamp:** 2025-05-07 10:34:07



### 9. Round Summary (Round 2)
**Timestamp:** 2025-05-07 10:34:52



### 10. Reflection (Round 3)
**Timestamp:** 2025-05-07 10:38:28



### 11. Proximity Check (Round 3)
**Timestamp:** 2025-05-07 10:39:39



### 12. Round Summary (Round 3)
**Timestamp:** 2025-05-07 10:41:07



### 13. Reflection (Round 4)
**Timestamp:** 2025-05-07 10:44:53



### 14. Proximity Check (Round 4)
**Timestamp:** 2025-05-07 10:45:31



### 15. Ranking (Round 4)
**Timestamp:** 2025-05-07 10:45:39



### 16. Round Summary (Round 4)
**Timestamp:** 2025-05-07 10:46:18



### 17. Tournament Results
**Timestamp:** 2025-05-07 11:00:51

**ELO Score:** 1203.3



### 18. Final Tournament Results
**Timestamp:** 2025-05-07 11:00:51

**ELO Score:** 1203.3



## Citations

- Krishnan 2021
- Mazmanian 1999
